Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tadalafil 40 mg
DRUG
2 trials
Sponsors
Actelion
, University Hospital Bispebjerg and Frederiksberg
Conditions
Fecal Incontinence
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Urinary Incontinence,Stress
Phase 1
Effects of Single Dose Tadalafil on Urethral and Anal Closure Function
Completed
NCT05095077
University Hospital Bispebjerg and Frederiksberg
Fecal Incontinence, Urinary Incontinence,Stress
Start: 2021-08-01
End: 2022-01-01
Updated: 2022-04-06
Phase 3
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Completed
NCT03904693
Actelion
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Start: 2019-07-29
End: 2024-09-27
Updated: 2025-12-19
Related Papers
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period
Advances in Therapy
2026-03-12
Macitentan Plus Tadalafil Single-Tablet Combination Therapy in Chinese Patients With Pulmonary Arterial Hypertension: A Subgroup Analysis of the A DUE Study.
2025-10-01
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
2024-01-01
37 citations
Macitentan tadalafil fixed dose combination (FDC) in patients with pulmonary arterial hypertension (PAH): A subgroup analysis from A DUE
2023-09-09